INSIGHTS ON DRUG DEVELOPMENT

  • Aggregate Analysis Of Semaglutide
    12/11/2025

    Effective size exclusion chromatography (SEC) for Semaglutide aggregate analysis is possible without high organic solvents or acidic modifiers. Learn about this robust method for improved efficacy.

  • Innovative Technology For Developing, Scaling Peptide-Based Therapeutics
    11/18/2024

    Watch as experts walk through several technologies and case studies, focusing on liquid-phase peptide synthesis, crystallization, method development for impurity analysis, and more.

  • The Body As A Bioreactor – Delivering The Vision
    8/8/2026

    Making the body a bioreactor requires precise delivery to selected cells. See how lipid nanoparticles, manufacturing science, and biology are converging to overcome biological barriers and improve the targeting of advanced therapies.

  • Enabling Quality By Design
    9/8/2025

    Outdated quality systems delay product release. Discover how manufacturers can harness real-time data, operationalize QbD, and enhance compliance, efficiency, and supply chain continuity.

  • Understanding Biotherapeutic Peptides And GLP-1 Receptor Agonists
    9/2/2025

    Biotherapeutic peptides offer enhanced safety and efficacy over traditional drugs. Learn why rigorous impurity profiling is vital to ensure product quality, patient safety, and regulatory compliance.

DRUG DEVELOPMENT SOLUTIONS